Barinthus Biotherapeutics plc (FRA:2AB)
Germany · Delayed Price · Currency is EUR 0.5000
-0.0150 (-2.91%)
Last updated: Jul 22, 2026, 8:07 AM CET
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of €21.7 million as of July 22, 2026. Its market cap has decreased by -58.13% in one year.
Market Cap
21.70M
Enterprise Value
-26.31M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.50
ChartMarket Cap Chart
Since April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from 399.28M to 21.70M, a decrease of -94.56%. That is a compound annual growth rate of -42.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 21.70M | -10.87% |
| Dec 31, 2025 | 24.35M | -48.13% |
| Dec 31, 2024 | 46.94M | -63.54% |
| Dec 29, 2023 | 128.74M | 56.98% |
| Dec 30, 2022 | 82.01M | -75.93% |
| Dec 31, 2021 | 340.74M | -14.66% |
| Apr 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 78.00M |
| 2invest AG | 45.07M |
| Biomark Diagnostics | 33.44M |
| Vidac Pharma Holding | 24.01M |
| co.don AG | 427.57K |
| Paion AG | 392.35K |
| bioXXmed AG | 225.65K |